Literature DB >> 8880940

Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs.

E D Levin1, P Kim, R Meray.   

Abstract

Chronic nicotine infusion has been found in a series of studies in our laboratory to significantly improve choice accuracy of rats in the eight-arm radial maze. The current study was designed to compare the effects of chronic nicotine infusion on working and reference memory in a 16-arm radial maze. Nicotine was administered to female Sprague-Dawley rats at approximately 5 mg/kg per day SC via osmotic minipumps. Controls received saline infusions. Chronic nicotine infusion significantly lowered the number of working memory errors compared to controls, whereas the number of reference memory errors was not significantly affected. The modest nicotine-induced reduction in working memory errors was seen as a main effect over the 4 weeks of infusion, but the clearest effect was seen in weeks 3-4 of nicotine administration. For the 2 weeks after withdrawal, the nicotine effect was no longer evident. Acute D1 challenges were given with the D1 agonist dihydrexidine (0, 0.25, 0.5 and 1 mg/kg) and the D1 antagonist SCH 23390 (0, 0.005, 0.015 and 0.05 micrograms/kg) during weeks 3-4 of chronic nicotine administration and weeks 1-2 after withdrawal from nicotine. Dihydrexidine caused a modest dose-related increase in reference memory errors but not working memory errors in the nicotine-treated, but not the control rats. The D1 antagonist SCH 23390 caused a modest though significant decrease in reference memory errors but not working memory errors in the control, but not the nicotine-treated rats. The behavioral specificity of chronic nicotine infusion was demonstrated with selective improvement in working memory function. Pharmacological interactions were seen with chronic nicotine treatment increasing responsivity to D1 agonist and decreasing responsivity to a D1 antagonist with regard to reference memory. The mechanisms of this interaction are still undiscovered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880940     DOI: 10.1007/bf02805971

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

Review 1.  Dissociating the effects of altered dopaminergic function on performance and learning.

Authors:  R J Beninger
Journal:  Brain Res Bull       Date:  1989 Oct-Nov       Impact factor: 4.077

Review 2.  Cholinergic-dopaminergic interactions in cognitive performance.

Authors:  E D Levin; S R McGurk; J E Rose; L L Butcher
Journal:  Behav Neural Biol       Date:  1990-11

3.  Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.

Authors:  E D Levin
Journal:  Behav Neural Biol       Date:  1988-09

4.  Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555.

Authors:  E D Levin; S R McGurk; J E Rose; L L Butcher
Journal:  Pharmacol Biochem Behav       Date:  1989-08       Impact factor: 3.533

5.  Nicotinic-dopaminergic relationships and radial-arm maze performance in rats.

Authors:  S R McGurk; E D Levin; L L Butcher
Journal:  Behav Neural Biol       Date:  1989-07

6.  Acute and chronic nicotine effects on working memory in aged rats.

Authors:  E D Levin; D Torry
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

7.  Chronic nicotine ingestion improves radial arm maze performance in rats.

Authors:  S. Poincheval-Fuhrman; S.J. Sara
Journal:  Behav Pharmacol       Date:  1993-10       Impact factor: 2.293

8.  Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats.

Authors:  E.D. Levin; J.E. Rose
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

9.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.

Authors:  E D Levin; C Lee; J E Rose; A Reyes; G Ellison; M Jarvik; E Gritz
Journal:  Behav Neural Biol       Date:  1990-03
View more
  21 in total

1.  Nicotine improves working memory span capacity in rats following sub-chronic ketamine exposure.

Authors:  Samantha L Rushforth; Thomas Steckler; Mohammed Shoaib
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 3.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

4.  Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats.

Authors:  Samuel S Shin; Eric R Bray; C Edward Dixon
Journal:  J Neurotrauma       Date:  2011-10-24       Impact factor: 5.269

5.  Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.

Authors:  Osamu Uchiumi; Yoshiyuki Kasahara; Asami Fukui; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Neuropharmacology       Date:  2012-07-15       Impact factor: 5.250

Review 6.  Cognitive enhancers for facilitating drug cue extinction: insights from animal models.

Authors:  Bríd Áine Nic Dhonnchadha; Kathleen M Kantak
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

Review 7.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

8.  Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.

Authors:  Nurith Amitai; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2008-07-11       Impact factor: 4.530

9.  Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.

Authors:  J D Raybuck; T J Gould
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

10.  Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats.

Authors:  A V Terry; D A Gearhart; S Warner; E J Hohnadel; M-L Middlemore; G Zhang; M G Bartlett; S P Mahadik
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.